Patients Are Using Internet for Interfertility Info, Providers Must Give Support
Providers could help patients whose needs are unmet find trustworthy resources on the internet.
Providers could help patients whose needs are unmet find trustworthy resources on the internet.
Boehringer plans to soon submit a new drug application for nerandomilast for treating PPF to the FDA.
An approval for sparsentan in focal segmental glomerulosclerosis would mark the second rare kidney disease approval for the agent.
Announced by LIB Therapeutics Inc., the agency has set a PDUFA target action date of December 12, 2025.
The Fast Track Designation was granted to Biodexa Pharmaceuticals’ eRapa based on phase 2 data showing its safety and tolerability in adults with FAP.
In this study, investigators highlighted factors associated with active hidradenitis suppurativa over the age of 50 such as smoking, male gender, and later onset of…
Test your knowledge of the 2023 Anaphylaxis Update from the Joint Task Force on Practice Parameters, focusing on diagnoses and biomarkers!
The drug given this designation, known as rezpegaldesleukin, is indicated for adult and pediatric patients aged 12 years and older with atopic dermatitis.
Adelaide Hebert, MD, discusses the impact of the recent approval for tapinarof cream in the management of atopic dermatitis.
In this analysis, investigators conclude that health-related quality of life and clinical burdens are greater among patients with hidradenitis suppurativa and draining tunnels.
These data suggest that the Family Acceptance and Commitment Therapy-based Eczema Management Program, or FACT-EMP, may be helpful to children with atopic dermatitis.